OS Therapies Valuation
| OSTX Stock | 3.97 0.06 1.53% |
At this time, the company appears to be undervalued. OS Therapies owns a latest Real Value of USD6.48 per share. The recent price of the company is USD3.97. Our model determines the value of OS Therapies from reviewing the company fundamentals such as shares outstanding of 20.88 M, and Total Debt of 14.61 M as well as analyzing its technical indicators and probability of bankruptcy.
Enterprise Value 90.7 M |
Undervalued
Today
Please note that OS Therapies' price fluctuation is very risky at this time. Calculation of the real value of OS Therapies is based on 3 months time horizon. Increasing OS Therapies' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since OS Therapies is currently traded on the exchange, buyers and sellers on that exchange determine the market value of OSTX Stock. However, OS Therapies' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.97 | Real 6.48 | Target 15.0 | Hype 3.72 | Naive 4.81 |
The intrinsic value of OS Therapies' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence OS Therapies' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of OS Therapies Incorporated helps investors to forecast how OSTX stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of OS Therapies more accurately as focusing exclusively on OS Therapies' fundamentals will not take into account other important factors: OS Therapies Cash |
|
OS Therapies Total Value Analysis
OS Therapies Incorporated is now anticipated to have valuation of 90.74 M with market capitalization of 74.14 M, debt of 14.61 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the OS Therapies fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
90.74 M | 74.14 M | 14.61 M |
OS Therapies Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of OSTX suggests not a very effective usage of assets in December.OS Therapies Ownership Allocation
OS Therapies secures a total of 20.88 Million outstanding shares. OS Therapies shows tangible amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company retains, if the real value of the company is less than the current market value, you may not be able to make money on it.OS Therapies Profitability Analysis
Net Loss for the year was (7.79 M) with profit before overhead, payroll, taxes, and interest of 0.About OS Therapies Valuation
Our relative valuation model uses a comparative analysis of OS Therapies. We calculate exposure to OS Therapies's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of OS Therapies's related companies.OS Therapies Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 20.6 M |
Additional Tools for OSTX Stock Analysis
When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.